Palbociclib with fulvestrant for treating hormone receptor-positive, HER2-negative, advanced breast cancer (Review of TA619) [ID3779]
In development [GID-TA10901] Expected publication date: 23 November 2022
In development [GID-TA10901] Expected publication date: 23 November 2022
In development [GID-TA10730] Expected publication date: 23 November 2022
In development [GID-TA10399] Expected publication date: 23 November 2022
In development [GID-TA10849] Expected publication date: 19 July 2023
In development [GID-TA10734] Expected publication date: 22 June 2022
In development [GID-TA10990] Expected publication date: TBC
In development [GID-TA10784] Expected publication date: TBC
In development [GID-TA10632] Expected publication date: TBC
In development [GID-TA10802] Expected publication date: TBC
In development [GID-TA10868] Expected publication date: TBC
In development [GID-TA10567] Expected publication date: 18 October 2023
In development [GID-TA10890] Expected publication date: 15 June 2022
In development [GID-TA10610] Expected publication date: 13 July 2022
In development [GID-TA10765] Expected publication date: TBC
In development [GID-TA10887] Expected publication date: TBC
In development [GID-TA10898] Expected publication date: 29 June 2022
In development [GID-TA10417] Expected publication date: 29 June 2022
In development [GID-TA10742] Expected publication date: 10 August 2022
In development [GID-TA10908] Expected publication date: 31 January 2023
In development [GID-TA10799] Expected publication date: TBC
In development [GID-TA10798] Expected publication date: TBC
In development [GID-TA10740] Expected publication date: 07 September 2022
In development [GID-TA10712] Expected publication date: 08 March 2023
In development [GID-TA10671] Expected publication date: 25 January 2023
In development [GID-TA10794] Expected publication date: 16 November 2022
In development [GID-TA10705] Expected publication date: 17 August 2022
In development [GID-TA10371] Expected publication date: 29 June 2022
In development [GID-TA10894] Expected publication date: 27 June 2022
In development [GID-MT538] Expected publication date: TBC
In development [GID-TAG423] Expected publication date: TBC
In development [GID-TA10377] Expected publication date: TBC
In development [GID-TA10635] Expected publication date: TBC
In development [GID-TA10356] Expected publication date: TBC
In development [GID-TAG367] Expected publication date: TBC
In development [GID-TAG373] Expected publication date: TBC
In development [GID-TA10467] Expected publication date: TBC
In development [GID-TA10598] Expected publication date: TBC
In development [GID-TAG413] Expected publication date: TBC
In development [GID-TA10199] Expected publication date: TBC
In development [GID-TAG436] Expected publication date: TBC
In development [GID-TA10544] Expected publication date: TBC
In development [GID-TA10327] Expected publication date: TBC
In development [GID-TA10341] Expected publication date: TBC
In development [GID-TA10337] Expected publication date: 19 February 2020
In development [GID-TA10382] Expected publication date: TBC
In development [GID-TAG278] Expected publication date: TBC
In development [GID-TA10853] Expected publication date: TBC
In development [GID-TA10330] Expected publication date: TBC
In development [GID-TA10203] Expected publication date: TBC
In development [GID-TA10149] Expected publication date: TBC